Back to search

Article

RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinoma

2022-07-08

Abstract excerpt

<title>Abstract</title> <p>Background: Severe hypoxia is a prominent character of pancreatic ductal adenocarcinoma (PDAC) microenvironment. In the process of gemcitabine based chemotherapy, PDAC cells are insulted from replication stresses co-induced by hypoxia and gemcitabine. However, PDAC cells get outstanding abilities to resist to such harsh conditions and keep proliferating, causing a major obstacle for cu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4fc94459-37f9-551c-8351-82c17bf25d94
DOI
10.21203/rs.3.rs-1799713/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinomaDOI 10.21203/rs.3.rs-1799713/v1
Select a neighboring publication to make it the new centre.